Literature DB >> 29471951

Contemporary Patterns of Early Coronary Angiography Use in Patients With Non-ST-Segment Elevation Myocardial Infarction in the United States: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry.

Carolina Malta Hansen1, Tracy Y Wang2, Anita Y Chen2, Karen Chiswell2, Deepak L Bhatt3, Jonathan R Enriquez4, Timothy Henry5, Matthew T Roe2.   

Abstract

OBJECTIVES: The study sought to characterize patient- and hospital-level variation in early angiography use among non-ST-segment elevation myocardial infarction (NSTEMI) patients.
BACKGROUND: Contemporary implementation of guideline recommendations for early angiography use in NSTEMI patients in the United States have not been described.
METHODS: The study analyzed NSTEMI patients included in ACTION (Acute Coronary Treatment and Intervention Outcomes Network) registry (2012 to 2014) who underwent in-hospital angiography. Timing of angiography was categorized as early (≤24 h) vs. delayed (>24 h). The study evaluated factors associated with early angiography, hospital-level variation in early angiography use, and the relationship with quality-of-care measures.
RESULTS: A total of 79,760 of 138,688 (57.5%) patients underwent early angiography. Factors most strongly associated with delayed angiography included weekend or holiday presentation, lower initial troponin ratio values, higher initial creatinine values, heart failure on presentation, and older age. Median hospital-level use of early angiography was 58.5% with wide variation across hospitals (21.7% to 100.0%). Patient characteristics did not differ substantially across hospitals grouped by tertiles of early angiography use (low, middle, and high). Hospitals in the highest tertile tended to more commonly use guideline-recommended medications and had higher defect-free care quality scores.
CONCLUSIONS: In contemporary U.S. practice, high-risk clinical characteristics were associated with lower use of early angiography in NSTEMI patients; hospital-level use of early angiography varied widely despite few differences in case mix. Hospitals that most commonly utilized early angiography also had higher quality-of-care metrics, highlighting the need for improved NSTEMI guideline adherence.
Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  NSTEMI; angiography; invasive strategy; performance measures

Mesh:

Year:  2018        PMID: 29471951     DOI: 10.1016/j.jcin.2017.12.016

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  5 in total

1.  Age, knowledge, preferences, and risk tolerance for invasive cardiac care.

Authors:  Michael G Nanna; Eric D Peterson; Angie Wu; Tina Harding; Anthony N Galanos; Lisa Wruck; Karen P Alexander
Journal:  Am Heart J       Date:  2019-10-23       Impact factor: 4.749

Review 2.  Acute Coronary Syndromes Among Patients with Prior Coronary Artery Bypass Surgery.

Authors:  Denada S Palm; Awa Drame; David J Moliterno; David Aguilar
Journal:  Curr Cardiol Rep       Date:  2022-09-12       Impact factor: 3.955

3.  Invasive treatment strategy in patients aged 80 years or older with non-ST-elevation acute coronary syndromes: a retrospective cohort study.

Authors:  Dai Zhang; Yun-Li Xing; Huan Wang; Shan Wang; Ye Miao; Wei Huang; Kan Zhang; Hong-Wei Li; Ying Sun; Hui Chen
Journal:  Cardiovasc Diagn Ther       Date:  2022-04

4.  Assessment of Pretreatment With Oral P2Y12 Inhibitors and Cardiovascular and Bleeding Outcomes in Patients With Non-ST Elevation Acute Coronary Syndromes: A Systematic Review and Meta-analysis.

Authors:  Luke P Dawson; David Chen; Misha Dagan; Jason Bloom; Andrew Taylor; Stephen J Duffy; James Shaw; Jeffrey Lefkovits; Dion Stub
Journal:  JAMA Netw Open       Date:  2021-11-01

5.  Optimal Timing of Invasive Coronary Angiography following NSTEMI.

Authors:  Thabo Mahendiran; David Nanchen; David Meier; Baris Gencer; Roland Klingenberg; Lorenz Räber; David Carballo; Christian M Matter; Thomas F Lüscher; Stephan Windecker; François Mach; Nicolas Rodondi; Olivier Muller; Stephane Fournier
Journal:  J Interv Cardiol       Date:  2020-03-03       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.